| NCT ID | NCT05468008 |
| Status | Recruiting |
| Phase | — |
| Sponsor | AdventHealth |
| Condition | Esophageal Lesion |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2022-02-04 |
| Primary Completion | 2027-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2022-02-04 with a primary completion date of 2027-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This registry is to evaluate the procedural and clinical outcomes in patients undergoing endoscopic submucosal dissection. All patients will receive standard of medical care and no experimental interventions will be performed.
Eligibility Criteria
Inclusion Criteria: * Age 18 years or older * Scheduled to undergo ESD Exclusion Criteria: * Any contraindication to performing endoscopy * Participation in another research protocol that could interfere or influence the outcomes measures of the present study.
Contact & Investigator
Dennis Yang, MD
PRINCIPAL INVESTIGATOR
AdventHealth Orlando
Frequently Asked Questions
Who can join the NCT05468008 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Esophageal Lesion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05468008 currently recruiting?
Yes, NCT05468008 is actively recruiting participants. Contact the research team at Dennis.Yang.MD@adventhealth.com for enrollment information.
Where is the NCT05468008 trial being conducted?
This trial is being conducted at Orlando, United States.
Who is sponsoring the NCT05468008 clinical trial?
NCT05468008 is sponsored by AdventHealth. The principal investigator is Dennis Yang, MD at AdventHealth Orlando. The trial plans to enroll 1,000 participants.